GCAC Files Patent Application for Cannabis on the Blockchain

Vancouver, British Columbia, Canada, December 19, 2019 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading developer of innovative data and AI technologies for the medical cannabis industry,  announced that it has filed a provisional method and composition patent application (Serial No. 62/950,158) with the U.S. Patent and Trademark Office (USPTO) for the System of Processing and Tracking Cannabis Products and Associated Method Using Blockchain. No assurance can be given as to whether or when a registered patent may be granted by the USPTO in the future.

A system and method of processing and tracking cannabis products includes a plurality of unique identifiers for a cannabis product, each associated with cannabis data that includes:

• data regarding the genetic profile of the seed used for the cannabis product
• data regarding the plant growth conditions of the crop used for the cannabis product
• data regarding the manufacture of the cannabis product
• data regarding the measurements of the quality and quantity of desired and undesired components in the cannabis product
• data regarding feedback from an end-user of the cannabis product.

The unique identifiers and cannabis data are stored in a plurality of data blocks of a blockchain, which are accessed by a cannabis processing server and processed to determine an end user treatment. This Patent Application was first filed in the USPTO to create a priority date, and allow for future filings in other selected jurisdictions, as appropriate, including Canada, Israel and the European Union.

GCAC’s Brad Moore, said “As regulators and the medical community demand trustworthy information about cannabis as a product and impact on users, GCAC’s unique processes and technology for storing cannabis data on the blockchain speaks directly to solving that problem. This patent application speaks specifically on how the company accomplishes this and utilizes its award-winning AI solution. It is the first of many related patent applications to be filed from the company as we continue to build trust and confidence in the cannabis industry and with our shareholders.”